Oxidative Stress Mechanisms Oxidative stress is defined as an imbalance between the production of reactive oxygen and nitrogen species (RONS) and the body's antioxidant defense systems. While RONS play essential roles in cell signaling and immune defense at physiological levels, their excessive accumulation damages vital macromolecules, including lipids, proteins, and DNA. Key damage mechanisms include lipid peroxidation (e.g., malondialdehyde, 4-HNE) which compromises cell membranes, protein carbonylation which impairs enzymatic function, and DNA lesions (e.g., 8-oxodG) which cause genomic instability.
Aging Theories The Free Radical Theory of Aging (FRTA), proposed in 1956, posits that cumulative oxidative damage is the primary driver of aging. This theory has evolved to encompass the "Signaling Disruption Theory" and "oxi-inflamm-aging," highlighting how oxidative stress disrupts redox signaling and fuels chronic low-grade inflammation. A major contributor to this process is mitochondrial dysfunction, where the electron transport chain becomes a primary source of superoxide anions, creating a feedback loop of cellular damage. Additionally, oxidative stress accelerates telomere shortening and induces cellular senescence, a state where non-dividing cells accumulate and secrete pro-inflammatory factors (SASP) that degrade surrounding tissue.
Related Diseases Oxidative stress is a unifying factor in the pathogenesis of numerous chronic degenerative conditions:
• Neurodegenerative Diseases: In Alzheimer's, Parkinson's, and ALS, oxidative stress drives protein aggregation (amyloid-beta, tau, alpha-synuclein), neuroinflammation, and excitotoxicity.
• Cardiovascular Disease (CVD): ROS promote endothelial dysfunction, atherosclerosis, and hypertension by impairing nitric oxide signaling and oxidizing LDL.
• Metabolic Disorders: In diabetes, oxidative stress damages pancreatic beta-cells and impairs insulin signaling pathways.
• Cancer: RONS-induced DNA damage and genomic instability promote mutagenesis and tumor progression.
• Other Conditions: Oxidative stress is implicated in chronic kidney disease, osteoarthritis, sarcopenia, skin diseases (e.g., psoriasis, vitiligo), and reproductive aging.
Therapeutic Interventions The body employs endogenous enzymatic antioxidants (SOD, catalase, glutathione peroxidase) and non-enzymatic molecules (glutathione, vitamins C and E) to neutralize free radicals. While dietary antioxidants are beneficial, clinical trials have shown mixed efficacy, shifting focus to targeted therapies. Emerging interventions include:
• Senolytics: Drugs like Dasatinib and Quercetin selectively eliminate senescent cells to reduce inflammation and improve endothelial function.
• Pathway Modulators: Activators of the Nrf2 pathway boost endogenous antioxidant gene expression.
• Pharmaceuticals: GLP-1 agonists and SGLT2 inhibitors are being investigated for their longevity and anti-oxidative effects.
• Lifestyle: Caloric restriction and exercise induce hormetic adaptations that enhance antioxidant defenses.